Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 407
Selected: 0
NCT IDTitle
NCT00100659PEDS-C: Pegylated Interferon +/- Ribavirin for Children With Hepatitis C
NCT04445272Clinical Trial to Evaluate the Effectiveness and Safety of Tocilizumab for Treating Patients With COVID-19 Pneumonia
NCT05798156Rituximab in Combination With Glofitamab and Polatuzumab Vedotin in Patients With Previously Untreated Aggressive B-cell Lymphoma Ineligible for R-CHOP
NCT05918666National Register of Actionable Mutations
NCT00963534Lenalidomide, Bendamustine and Rituximab as First-line Therapy for Patients Over 65 Years With Mantle Cell Lymphoma.
NCT01767597Application of HBV Rapid Tests as a Tool for Wide-Use Screening
NCT05470595A Single-arm Trial of Atezolizumab/Platinum/Etoposide for the Treatment of Advanced Large-cell Neuroendocrine Cancer of the Lung
NCT01558167A Safety and Efficacy Trial of a Combination of Bendamustine, Rituximab and Lenalidomide in Patients With Chronic Lymphocytic Leukemia
NCT02987400Combination of Obinutuzumab and Venetoclax in Relapsed or Refractory DLBCL
NCT00333736Study to Assess Safety and Quality of Life of Patients Using Biojector Versus Needles for Fuzeon Administration
NCT04335071Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19)
NCT01944943Phase II Study of Vismodegib in Patients With Refractory or Relapsed B-cell Lymphoma or Chronic Lymphocytic Leukemia
NCT00285233Delayed Mycophenolate Mofetil in Single-Donor Islet Allotransplantation in Type 1 Diabetes
NCT06068998Molecular Characterization of Penile Cancers in Developing Countries
NCT03802604Combination of Talimogene Laherparepvec With Atezolizumab in Early Breast Cancer
NCT01690325Imaging for Response Assessment of Neoadjuvant Chemotherapy in Primary Breast Cancer (GALADON)
NCT00753155Prospective Intervention Study to Improve HRQoL and Exercise Tolerance After Lung Transplantation (Ergo-LTx)
NCT03455582Cognition Evolution and MRI Markers in PPMS Patients on 2 Years
NCT01953458Therapeutic Option for Hepatitis B and C: a French Cohort
NCT01249638Cap+Bev vs Cap+Iri+Bev 1st-line Therapy in mCRC
NCT03915678Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors
NCT05651724Global Research Initiative for Patients Screening on MASH
NCT00459771Evaluating the Effect of Candesartan vs Placebo in Prevention of Trastuzumab-associated Cardiotoxicity
NCT00252642Peginterferon Alpha-2a Maintenance Therapy for Portal Hypertension in Patients With Hepatitis C
NCT03577197Southeast Netherlands Advanced Metastatic Breast Cancer Registry
NCT00150891Th1, Th2 and Monokine Responses as Risk Factors of Renal Transplant Rejection
NCT01126866Curative Resectability of Not Optimally Resectable Liver and/or Lung Metastases From Colorectal Carcinoma (CRC) Under Intensified Chemotherapy
NCT02064491Erlotinib Treatment Beyond Progression in EGFR Mutant NSCLC
NCT00217152A Kidney Transplant Study to Look at the Effects of Taking Fixed Doses of CellCept Versus Taking Doses of CellCept Based on the Concentration of CellCept in the Blood When Taking Full or Reduced Dose Calcineurin Inhibitors
NCT05057234PRecision Oncology Evidence Development in Cancer Treatment - Liquid
NCT04292574UK SMA Patient Registry
NCT00536640Inoperable Non-Squamous NSCLC Stage III/IV: A Randomised Phase II Study With Bevacizumab Plus Erlotinib Or Gemcitabine/Cisplatin Plus Bevacizumab
NCT04363853Tocilizumab Treatment in Patients With COVID-19
NCT00944684High Dose Ribavirin in the Treatment of Chronic Hepatitis C
NCT04245085ABC-lung: Atezolizumab, Bevacizumab and Chemotherapy in EGFR-mutant Non-small Cell Lung Carcinoma
NCT01085838Erlotinib in Higher Risk Myelodysplastic Syndrome
NCT04161248Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma
NCT00405587Safety Study of PLX4032 in Patients With Solid Tumors
NCT00562952Nt-proBNP Guided Primary Prevention of CV Events in Diabetic Patients
NCT03721484CINtec PLUS Triage in HPV Primary Screening
NCT00842114Rituximab and CVP Plus Interferon for Follicular Non Hodgkins Lymphoma (NHL)
NCT01593332Low Dose Rituximab as a First Line Biologic Therapy for the Treatment of DMARD Resistant Patients With Rheumatoid Arthritis
NCT01752335Effect of Monoclonal Anti-IL6 Antibody (Tocilizumab) on the Cardiovascular Risk in Patients With Rheumatoid Arthritis
NCT02562378T-DM1 and Non-pegylated Liposomal Doxorubicin in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer
NCT07670117HAIQU (Hospital AIr QUality)
NCT01898117Triple-B Study;Carboplatin-cyclophosphamide Versus Paclitaxel With or Without Atezolizumab as First-line Treatment in Advanced Triple Negative Breast Cancer
NCT04400474Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study
NCT04653831Treatment With Pirfenidone for COVID-19 Related Severe ARDS
NCT03892525Study of Intratumoral Selicrelumab With Atezolizumab in Patients With Refractory or Relapsed B Cell Lymphoma
NCT03554343Sun May Arise on SMA : Newborn Screening of Spinal Muscular Atrophy in Belgium